.
MergerLinks Header Logo

New Deal


Announced

Completed

Bayer completed the acquisition of a 70% stake in Care/of for $225m.

Financials

Edit Data
Transaction Value£168m
Consideration TypeCash
Capital Owned-
Capital Bid For70%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

health products

Pharmaceuticals

Private

Majority

United States

Single Bidder

Acquisition

vitamin supplements

Friendly

Completed

Cross Border

Disposal

Private Equity

Synopsis

Edit

Bayer, a German multinational pharmaceutical and life sciences company, completed the acquisition of a 70% stake in Care/of, a vitamin subscription service provider, for $225m. "We believe this model and product type has the ability to expand into traditional retail channels as we aim to reach new consumers. Together we plan to grow the Care/of business across new channels, new categories and new markets to deliver even more personalized nutrition," Dan Childs, Bayer spokesman.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US